Underskott för staten i juni 2020
Statens betalningar resulterade i ett underskott på 56,5 miljarder kronor i juni. Riksgäldens prognos var ett underskott på 70,5 miljarder kronor. Skillnaden beror till större delen på högre skatteinkomster än beräknat.
Det primära saldot blev 13,9 miljarder kronor högre än prognosticerat. Större delen av skillnaden förklaras av att skatteinkomsterna blev cirka 10 miljarder kronor högre än beräknat. Statistik som visar effekterna inom de olika skatteslagen saknas ännu. Statistik för maj månad visade bland annat att inbetalningarna av löneskatter och bolagsskatt var högre än beräknat.
Riksgäldens nettoutlåning till myndigheter m.fl. var 0,1 miljarder kronor lägre än beräknat.
Räntebetalningarna på statsskulden var 0,1 miljarder kronor högre än prognos.
För tolvmånadersperioden till och med juni 2020 visade statens betalningar ett underskott på 58,0 miljarder kronor.
Statsskulden uppgick till 1 158 miljarder kronor i slutet av juni.
Utfallet för juli 2020 publiceras den 7 augusti, kl. 09.30.
Kontakt
Pressfunktionen, 08 613 47 01
| Statens budgetsaldo och nettolånebehov1 (miljoner kronor) | |||||
| Utfall juni | Prognos juni | Differens juni | Ack. diff.2 | Utfall 12-mån | |
| Budgetsaldo | -56 525 | -70 464 | 13 938 | 41 558 | -58 050 |
| Nettolånebehov1 | 56 525 | 70 464 | -13 938 | -41 558 | 58 050 |
| Primärt saldo3 | 58 198 | 72 106 | -13 908 | -36 738 | 73 106 |
| Nettoutlåning till myndigheter m.fl.4 | -4 249 | -4 166 | -83 | -3 965 | -32 936 |
| Räntor på statsskulden | 2 576 | 2 523 | 53 | -856 | 17 880 |
| - Ränta på lån i svenska kronor | 3 571 | 3 103 | 468 | -168 | 12 413 |
| - Ränta på lån i utländsk valuta | -73 | -66 | -7 | -26 | -615 |
| - Realiserade valutakursdifferenser | -922 | -514 | -408 | -661 | 6 082 |
| 1 Nettolånebehovet motsvarar budgetsaldot med omvänt tecken. | |||||
| 2 Summan av månatliga prognosdifferenser sedan senaste prognos (maj 2020). | |||||
| 3 Nettot av statens primära utgifter och inkomster. | |||||
| 4 Nettot av myndigheter med fleras in- och utlåning i Statens internbank. Nettoutlåningen innehåller såväl löpande statlig verksamhet som tillfälliga poster, vilka kan beslutas med kort varsel. In- och utlåningen påverkar nettolånebehovet och statsskulden, men omfattas inte av det statliga utgiftstaket. | |||||
Statistik om nettolånebehovet, statens upplåning och statsskulden:
https://www.riksgalden.se/sv/statistik/statistik-om-statens-upplaning/
Det månatliga utfallet av statens nettolånebehov ingår i Sveriges officiella statistik.
Riksgälden publicerade sin senaste prognos över Sveriges ekonomi och statens upplåning den 19 maj: Statsupplåning prognos och analys 2020:2.
Bilaga
För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.Om
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Följ GlobeNewswire by notified
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från GlobeNewswire by notified
Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release
Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10
Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release
Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of
RomReal 2023 Annual report including accounts and Audit statement19.4.2024 21:00:00 CEST | Press release
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments ANNUAL REPORT RomReal and Financial statements 2023Independent auditors report RomReal 2023
Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release
The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and
SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release
Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie